Chiesi Farmaceutici S.p.A: Clinical Trials & Research Profile
Biopharma Industry (Global / Institutional) · Primary Focus: Respiratory and Pulmonary
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (Global / Institutional) |
| Primary Therapeutic Area | Respiratory and Pulmonary |
| Active Phase II & III Studies | 10 active (7 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 33 (9 with California sites) |
| Completed vs Early-Stopped Studies | 13 completed / 10 stopped (30.3% stop rate) |
| Median Closed Enrollment | 103 participants |
| FDA Drugs@FDA Original Approvals | 0 all-time (0 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 95.9% named hospital slots |
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk